News

QT Activity: Webinar Recap | Medical Device Studies in the US: Regulatory Requirements, Study Design, and Best Practices in Subject Management – March/April 2026

QT Activity: Webinar Recap | Medical Device Studies in the US: Regulatory Requirements, Study Design, and Best Practices in Subject Management – March/April 2026

  • 2026-04-23 07:36:58

The webinar hosted by Qualtech in March takes a closer look at how medical device studies are conducted in the United States. Covering US FDA classification, IDE and IRB pathways, and study design, it connects regulatory frameworks with their practical application in study execution. This recap highlights key considerations shaping how studies are structured and managed in the US context.

More
QT Activity: Southeast Asia Medical Device Compliance Update 2025 Webinar Recap Part 2: Singapore, Malaysia & the Philippines – November/December 2025

QT Activity: Southeast Asia Medical Device Compliance Update 2025 Webinar Recap Part 2: Singapore, Malaysia & the Philippines – November/December 2025

  • 2025-12-26 04:07:51

Qualtech 2025 Southeast Asia Medical Device Compliance Update Webinar Part 2 provides an overview of key regulatory updates in Singapore, Malaysia & the Philippines. The session highlights changes in ASEAN medical device regulations, including system upgrades, regulatory reliance initiatives, evolving submission and classification requirements by Singapore HSA, Malaysia MDA & Philippines FDA, offering insights for medical device compliance planning in 2026.

More
QT Activity: Southeast Asia Medical Device Compliance Update 2025 Webinar Recap Part 1: Indonesia, Thailand & Vietnam – October/November 2025

QT Activity: Southeast Asia Medical Device Compliance Update 2025 Webinar Recap Part 1: Indonesia, Thailand & Vietnam – October/November 2025

  • 2025-11-26 07:23:46

This article summarizes key insights from Qualtech's 2025 ASEAN regulatory webinar, highlighting major updates in Indonesia, Thailand and Vietnam. The recap covers changes in retail rules, procurement, halal enforcement, reliance pathways and registration procedures, reflecting how these markets are streamlining medical device approvals and improving regional market access.

More
QT ACTIVITY: QUALTECH AT CMEH 2025 BEIJING – EXPLORING NEW PATHWAYS FOR CHINESE MEDTECH GLOBALIZATION – SEPTEMBER 2025

QT ACTIVITY: QUALTECH AT CMEH 2025 BEIJING – EXPLORING NEW PATHWAYS FOR CHINESE MEDTECH GLOBALIZATION – SEPTEMBER 2025

  • 2025-10-27 06:25:03

Qualtech participated in the 46th China International Medical Equipment Exhibition (CMEH 2025) in Beijing, engaging with leading domestic manufacturers and industry experts to explore new pathways for Chinese MedTech globalization. The event served as a valuable platform for dialogue on international market expansion, regulatory challenges, and compliance strategies. As a trusted regulatory partner, Qualtech remains dedicated to helping Chinese innovators bring their high-quality medical devices to the global stage.

More
QT ACTIVITY: Entering Japan & South Korea – Understanding PMDA & MFDS Requirements for Medical Devices WEBINAR RECAP - AUGUST/SEPTEMBER 2025

QT ACTIVITY: Entering Japan & South Korea – Understanding PMDA & MFDS Requirements for Medical Devices WEBINAR RECAP - AUGUST/SEPTEMBER 2025

  • 2025-09-24 09:35:21

On September 4, 2025, Qualtech hosted a webinar focusing on the medical device regulatory landscapes of Japan and South Korea. Led by our Japan and South Korea Registration Team Leaders, the session offered participants a structured overview of both markets, covering regulatory frameworks, registration pathways, and key updates shaping compliance today.

More
QT ACTIVITY: WHY AUSTRALIA IS THE IDEAL PARTNER FOR YOUR NEXT CLINICAL TRIAL WEBINAR RECAP - JULY/AUGUST 2025

QT ACTIVITY: WHY AUSTRALIA IS THE IDEAL PARTNER FOR YOUR NEXT CLINICAL TRIAL WEBINAR RECAP - JULY/AUGUST 2025

  • 2025-08-25 07:56:48

On July 21, 2025, Qualtech hosted a webinar featuring Mobius Medical's Co-Founder and Clinical Director, Stefan Czyniewski, on "Accelerating Innovation: Why Australia Is the Ideal Partner for Your Next Clinical Trial". The session emphasized Australia’s speed and cost-efficiency under the Clinical Trial Notification (CTN) scheme, world-class infrastructure, and broad international acceptance of trial data. Key comparisons with the United States highlighted faster start-up timelines, simpler regulatory pathways, and substantial financial incentives such as the R&D Tax Rebate. With its favorable environment for early-phase medical device and diagnostic studies, Australia stands out as a strategic launchpad for global clinical development.

More
QT ACTIVITY: NAVIGATING INDIA'S MEDICAL DEVICE REGULATORY LANDSCAPE WEBINAR RECAP - MAY/JUNE 2025

QT ACTIVITY: NAVIGATING INDIA'S MEDICAL DEVICE REGULATORY LANDSCAPE WEBINAR RECAP - MAY/JUNE 2025

  • 2025-06-03 07:01:37

On April 24, 2025, Qualtech hosted a webinar focused on navigating the regulatory landscape for medical devices in India. The session was presented by Mr. Anil Chaudhari, Founder and CEO of Operon Strategist, and Ms. Lakshmi Ranjith, Manager of Regulatory Affairs of Operon Strategist. Together, they provided a detailed overview of India’s regulatory system, including the roles of CDSCO and state licensing authorities, the classification of medical devices by risk level, the registration process, and best practices for compliance. The following summary highlights the key insights and essential regulatory requirements, offering valuable guidance for medical device companies seeking to enter or expand in the India market.

More
QT Activity: Medical Device Approval in Australia – What You Need to Know in 2025 Webinar Recap – April/May 2025

QT Activity: Medical Device Approval in Australia – What You Need to Know in 2025 Webinar Recap – April/May 2025

  • 2025-04-24 09:48:40

On March 26, 2025, Qualtech hosted a regulatory webinar exploring the process of medical device approval in Australia. The session covered essential topics including device classification, conformity assessment options, ARTG registration steps, sponsor and manufacturer obligations, post-market surveillance, and upcoming UDI requirements. Practical tips and FAQs helped attendees better prepare for TGA submissions and long-term compliance in the Australian market.

More